Expressed fusion gene landscape and its impact in multiple myeloma

por Cleynen, A., Szalat, R., Kemal Samur, M., Robiou du Pont, S., Buisson, L., Boyle, E., Chretien, M. L., Anderson, K., Minvielle, S., Moreau, P., Attal, M., Parmigiani, G., Corre, J., Munshi, N., Avet-Loiseau, H.
Publicado 2017

P956: EMMY COHORT: MANAGEMENT OF NEWLY DIAGNOSED OR RELAPSED/ REFRACTORY MULTIPLE MYELOMA IN PATIENTS AGED OF 80 YEARS AND OVER

por Macro, M., Decaux, O., Perrot, A., Royer, B., Chretien, M., Belhadj, K., Mohty, M., Frenzel, L., Leleu, X., Dib, M., Allangba, O., Zunic, P., Botoc, I., Malfuson, J., Moreau, P., Garlantazec, R., Texier, N., Germain, R., Deal, C., Hulin, C.
Publicado 2022

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents

por Duchmann, M, Braun, T, Micol, J-B, Platzbecker, U, Park, S, Pilorge, S, Beyne-Rauzy, O, Vey, N, Sébert, M, Gruson, B, Dumas, P-Y, Guieze, R, Chretien, M-L, Laribi, K, Chait, Y, Legros, L, Sahnes, L, Hirsch, P, Salanoubat, C, Solary, E, Fenaux, P, Itzykson, R
Publicado 2017

P872: DEL(1P32) REMAINS A POWERFUL PROGNOSTIC FACTOR IN A LARGE COHORT OF NDMM PATIENTS: AN UPDATE

por Schavgoulidze, A., Perrot, A., Cazaubiel, T., Leleu, X., Manier, S., Buisson, L., Maheo, S., Do Souto Ferreira, L., Lannes, R., Pavageau, L., Hulin, C., Marolleau, J.-P., Voillat, L., Belhadj, K., Divoux, M., Slama, B., Brechignac, S., Macro, M., Stoppa, A.-M., Sanhes, L., Orsini-Piocelle, F., Fontan, J., Chretien, M.-L., Demarquette, H., Mohty, M., Avet-Loiseau, H., Corre, J.
Publicado 2022